fme Life Sciences Expands Senior Management Team

Danbury - March 10, 2022 : fme Life Sciences, a leading provider of business and technology services supporting the deployment of Business Applications and Content Services, announces Ian Crone and David Gwyn as Business Unit Directors. With these appointments, fme Life Sciences lays the foundation for future growth in Europe and North America.

Contact us

Would you like more information? Please contact Tina Lenitzki at +49 531-23854-0 or send an e-mail to t.lenitzki@fme.de.de

Ian Crone brings more than 20 years of experience in the Life Sciences industry to the role of Business Unit Director for Europe at fme Life Sciences.  Ian’s background is in chemical engineering which is the subject of both his university degree at Strathclyde University in Scotland and the first fourteen years of his career at Unilever. Over the two decades since, Ian has been involved in the chemical and pharmaceutical industry, from every angle of drug development and for some of the largest Life Sciences companies. He has gathered experiences both from an industry and the technology/services supply side, in roles held at Oxford Instruments, BioStorage Technologies and Samarind.
David Gwyn is a strategic, creative, and data-driven Business Development and Technology Specialist with extensive expertise in building key partnerships, implementing business strategies, and deploying solutions across the life science and emerging technology industries. David joined as the Business Unit Director for Business Consulting at fme Life Sciences in North America. For the past 30 years, David has led teams in the delivery of content management, clinical, and quality solutions with a recent focus on end-to-end Regulatory Information Management (RIM). His experience has evolved in parallel to the Life Sciences industry, moving from custom-developed software solutions to packaged-based implementations, and the development of methodologies and best practices to guide practitioners in realizing the greatest return on investment.

“With the breadth of knowledge and experience that both Ian and David bring to fme Life Sciences, we feel they will have immediate impact in further developing our client relationships and expanding our business” states Nigel Whitehead COO of fme Life Sciences.

About fme

Digitalization enables new ways of dealing with existing businesses and creates totally new business models. We believe in the opportunities of digital transformation and love to help our clients worldwide maintain and create competitive businesses with business consulting and technology services. Our devoted consultants optimize or challenge our clients’ business models through existing and new technologies and advise them on the necessary cultural change in their company. Cloud, Business Intelligence, Collaboration and Enterprise Content Management technologies in combination with custom software development and the ability to operate our clients’ systems 24×7 help us to add value to our clients’ transformation process.

The industry focus lies on solutions for life sciences, industrial manufacturing and financial services. To this effect, we provide vendor independent consulting services. Our teams in Germany, the United States and Romania are experienced in managing global projects and also grant access to our cost-effective near-shore resources where advisable.

For 25 years, renowned corporations like Boehringer Ingelheim, BMW, CSL Behring, Debeka, EagleBurgmann, Merck, Sanofi-Aventis, Volkswagen and Volkswagen Financial Services have relied on our experience and competence. We are a privately held company and have enjoyed uninterrupted and profitable growth over the years resulting in a comfortable shareholder equity rate.